IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (Nasdaq:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and …
Ophthotech Reports Third Quarter 2015 Financial and Operating Results
NEW YORK–(BUSINESS WIRE)–Ophthotech Corporation today announced financial results for the third quarter ended September 30, 2015 and provided an update on the Company’s business and product development programs.
NovaBay Pharmaceuticals to Hold Third Quarter 2015 Conference Call on November 13
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals to report third quarter 2015 financial results and hold an investment community conference call on Friday, November 13, 2015.
No Link Between Oral Fluoroquinolones, Uveitis in Large Study
According to a new retrospective study, there are no data to support an association between the use of oral fluoroquinolones and an increased risk for uveitis. Medscape Medical News
JEDI T-cells provide unique technology to study, visualize immune responses and immunotherapies
When it comes to fending off disease and helping prevent people from falling ill, the body’s immune system — armed with T-cells that help eliminate cancer cells, virus-infected cells and more — is second to none. But exactly how the immune system wor…
Get Ready for MIPS — or Opt Out
(MedPage Today) — Medicare’s newest quality reporting program will look at data from 2017